Mid cap
Mirae Asset crosses 5% in Equitas SFB
A routine SEBI disclosure. Mirae bought 0.851% on June 4, worth ₹71 crore—less than 1% of the bank's market cap.
ixigo buys controlling stake in micro-stay hotel platform Brevistay for ₹65.7 cr
The ₹65.7 crore cash deal is ixigo's first major M&A move, adding flexible-duration hotel bookings to its platform. The board also approved ₹12 crore for two AI startups.
Lumax Auto plans full JOPP exit, targets 20% annual growth
Record ₹4,870 cr revenue and a ₹1,450 cr three-year order book set the stage. Management is now reshaping the portfolio.
Concord Biotech expects growth to return in FY27 after profit dropped 30%
The API maker's net profit fell to ₹259 crore in FY26 as geopolitical disruptions hurt sales. Management now guides for a double-digit revenue rebound in the first half of FY27.
IFB Industries posts FY26 numbers again. This time in a slide deck.
The investor presentation breaks out the audited results by division. The core ₹5,476 cr revenue and ₹133 cr profit were already public.
Ion Exchange profit margins shrink as Roha plant costs bite
EBITDA margins fell to 2.31% despite a 3% revenue rise, as new manufacturing lines came online and West Asia operations remained under pressure.
Knowledge Marine accelerates ₹285 cr fund deployment, shelves Bahrain on geopolitics
The shipbuilder is now spending its preferential capital in 12-16 months, not three years, and holding EBITDA margins at 35-40% as it targets 30% annual revenue growth.
Nesco walks away from all four Raipur-Vizag expressway sites
The company is surrendering the leases, citing unrest, poor infrastructure and regulatory hurdles. The financial hit is unquantified.
GMR shuffles ₹801 cr between promoter arms. Control consolidates.
GMR Estate Management buys a 9.55% stake from GMR Enterprises. Total promoter holding doesn't change, but the internal hierarchy does.
GMR promoter clears 15.36% share pledge weeks after creating it for ₹350 cr
GMR Estate Management freed 12 crore shares from a pledge created just weeks earlier to secure a debenture facility.
Olectra files its FY26 call transcript. It adds nothing new.
A routine filing of the June 1 earnings call transcript. The numbers and commentary were already public.
Alembic lands generic Haldol approval, but the US market is tiny
Final USFDA clearance for Haloperidol Tablets adds to a 240-product pipeline. The market it addresses is less than 3% of Alembic's revenue.
HCC lands ₹127 cr Bhutan hydro contract, adds to Bhutan pipeline
The Wangchhu project win is small at 2% of market cap but continues HCC's 30-year run in Bhutanese hydropower.
Axiscades deferred ₹142 cr in Q4; FY27 guidance holds at ₹1,377 cr
Supply-chain snags on defence programs pushed revenue into the new year. Management says the deferred ₹142 crore will show up in H1 FY27.
AvenuesAI wins UAE central bank license to sell retail payment services directly.
The in-principle approval lets its subsidiary offer a full suite of digital payment solutions in the UAE, moving beyond a restricted service role.
Sudarshan's promoter family plans to step back from management
The quarterly transcript reveals a strategic shift toward professionalization, with the Heubach acquisition turning profitable and debt falling to ₹755 cr.
Maharashtra FDA seizes FDC's Enerzal stock over misbranding allegations
The regulator collected samples and cleared warehouses in Nagpur and Chhatrapati Sambhaji Nagar. FDC says the financial impact is not material.
Jupiter Wagons' FY26 profit fell. The wheelset shortage is the culprit.
A global parts shortage hit wagon output. The Odisha plant meant to fix it is six months late.
Jyoti CNC puts ₹67 crore on ice at its French unit pending investigation
The Q4 call added one new number to the story: the revenue deferred at Huron. Everything else was a repeat of audited results.
TBO Tek lost ₹30-50 cr in March to Middle East conflict.
The one-month EBITDA hit from geopolitics was real. The April recovery was also real. Now the Classic Vacations integration and a new AI platform must deliver the growth.
Ashapura's Guinea port delayed 18 months, iron ore launch indefinite
The company's two key growth bets in Guinea are now behind schedule. The port expansion slips to FY28 and commercial iron ore is undated.
Triveni's sugar crush missed guidance. Distillery hit a record.
Sugarcane volumes fell 8.8% after weather and crop diversion wrecked management's growth outlook. Distillery revenues hit ₹1,550 crore.
Greenlam guides 18-20% FY27 growth, targets break-even for chipboard and plywood
Chipboard and plywood are both targeting EBITDA break-even this fiscal year. Laminates margins are forecast to hold at 16-17%.
Natco's FY27 guide stays put: ₹3,400-3,500 cr revenue, ₹700-750 cr PAT
The Q4 call transcript adds detail on Semaglutide and M&A but confirms numbers already guided. The investment thesis is unchanged.
Cello's writing instruments jumped 64%. Glassware stayed at breakeven.
One segment is carrying the company. Chinese dumping has the other stuck. FY27 guidance is 10-12% revenue growth and ₹100 cr in capex.